Anca Zgură

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 52 citations · Full text

Differential Effectiveness, Urology, Genitourinary Cancer +7

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Matteo Santoni, Francesco Massari, Zin Myint et al. · Targeted Oncology · 2023 · 34 citations · Full text

Immuno-oncology Combinations, Urology, Kidney Transplant +7

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Matteo Santoni, Francesco Massari, Zin Myint et al. · Clinical Genitourinary Cancer · 2023 · 26 citations · Full text

Immuno-oncology Combinations, Urology, Genitourinary Cancer +7

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Ondřej Fiala, Sebastiano Buti, Hideki Takeshita et al. · Cancer Immunology Immunotherapy · 2023 · 26 citations · Full text

Urology, Metastatic Urothelial Carcinoma, Genitourinary Cancer +6

Electrocardiographic Changes in Liver Cirrhosis—Clues for Cirrhotic Cardiomyopathy

Letiția Toma, Adriana Mercan Stanciu, Anca Zgură et al. · Medicina · 2020 · 18 citations · Full text